Today's Information |
Provided by: MAXIGEN BIOTECH INC. | |||||
SEQ_NO | 2 | Date of announcement | 2022/06/06 | Time of announcement | 18:26:30 |
Subject | Monthly revenue report, May 2022 | ||||
Date of events | 2022/06/06 | To which item it meets | paragraph 51 | ||
Statement | 1.Date of occurrence of the event:2022/06/06 2.Company name:Maxigen Biotech Inc 3.Relationship to the Company (please enter "head office" or "subsidiaries"):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:N/A 6.Countermeasures:N/A 7.Any other matters that need to be specified: Maxigen Biotech Inc. (TWSE: 1783) today announced its net revenues for May 2022. On a consolidated basis, revenues for May 2022 were approximately NT$ 52.411 million, an increase of 21.57 percent over the same period in 2021. Revenues for January through May 2022 totaled NT$ 215.144 million, an increase of 16.90 percent compared to the NT$ 184.041 million for the same period in 2021. |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Maxigen Biotech Inc. published this content on 06 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 June 2022 10:31:10 UTC.